Centene Corp
CNC: XNYS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$19.00 | Lnphs | Rdytlstd |
Centene Delivers Strong Q3 and Gives Solid Intermediate-Term Profit Goals; No FVE Change
Narrow-moat Centene turned in solid third-quarter results, including strong performance in its key end markets—Medicaid (low-income Americans) and Medicare Advantage (older Americans)—which allowed management to slightly increase the bottom end of its 2022 EPS outlook. Also, on the call, management gave a preview of its 2023 and 2024 profit goals, which are roughly in line with our estimates. Considering that solid outlook, we are maintaining our $95 fair value estimate.